Codes / ICD10CM / A18.83

A18.83 Tuberculosis of digestive tract organs, not elsewhere classified

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Tuberculosis of digestive tract organs, not elsewhere classified
  • ICD Code: A18.83

Summary

Tuberculosis of digestive tract organs, not elsewhere classified, is a form of extrapulmonary tuberculosis where Mycobacterium tuberculosis infects organs within the digestive tract that are not classified under more specific subcategories. This condition occurs when TB bacteria spread from a primary site, typically the lungs, to the digestive tract via the bloodstream or lymphatic system. It can affect structures such as the stomach, small intestine, or colon, depending on the site of dissemination.

Causes

Tuberculosis of digestive tract organs is caused by the spread of Mycobacterium tuberculosis from an existing infection, usually pulmonary tuberculosis. The bacteria can travel to the digestive tract during active disease or reactivation of latent TB. Direct ingestion of infected material is rare but possible in certain cases.

Risk Factors

  • Immunocompromised states, such as HIV/AIDS or chronic steroid use.
  • History of untreated or inadequately treated tuberculosis.
  • Close contact with individuals who have active TB.
  • Living in or traveling to regions with high TB prevalence.
  • Underlying conditions like diabetes or malnutrition.

Symptoms

  • Abdominal pain or discomfort.
  • Nausea or vomiting.
  • Changes in bowel habits, such as diarrhea or constipation.
  • Unexplained weight loss.
  • Fever or night sweats.
  • Loss of appetite.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies (e.g., CT or MRI of the abdomen), and laboratory tests. Stool samples or tissue biopsies may be analyzed for Mycobacterium tuberculosis using acid-fast staining or molecular testing. Endoscopic procedures may be performed to visualize and sample affected areas. A thorough medical history, including TB exposure or prior infection, is also considered.

Treatment Options

Treatment typically follows standard anti-tuberculosis regimens, including a combination of antibiotics such as isoniazid, rifampin, ethambutol, and pyrazinamide. The duration of therapy is usually 6–12 months, depending on the severity and response to treatment. Surgical intervention may be necessary in cases of obstruction, perforation, or severe tissue damage.

Prognosis and Follow-Up

With appropriate treatment, the prognosis is generally favorable, though recovery may take several months. Regular follow-up is essential to monitor for treatment response, side effects, and potential complications. Patients should complete the full course of therapy to prevent relapse or drug resistance.

Complications

  • Bowel obstruction or perforation.
  • Malabsorption or nutritional deficiencies.
  • Fistula formation between digestive organs.
  • Spread of infection to other parts of the body.
  • Drug-resistant TB if treatment is incomplete or ineffective.

Lifestyle & Prevention

  • Maintain good hygiene practices, especially in high-risk settings.
  • Ensure proper ventilation in living or work environments.
  • Follow public health guidelines for TB screening and prevention.
  • Seek prompt treatment for latent or active TB to reduce dissemination risk.
  • Support immune health through balanced nutrition and regular medical care.

When to Seek Professional Help

Consult a healthcare provider if you experience persistent abdominal pain, unexplained weight loss, fever, or changes in bowel habits, especially if you have a history of TB exposure or infection. Seek immediate care for severe symptoms like vomiting, bloody stools, or signs of bowel obstruction.

Tips for Medical Coders

When coding A18.83, ensure the documentation specifies involvement of digestive tract organs not classified elsewhere (e.g., stomach, small intestine, colon) and excludes more specific sites like the esophagus or peritoneum. Verify that the diagnosis aligns with clinical findings and that no other codes (e.g., for pulmonary TB) are required to capture the full clinical picture. Document the affected organ(s) clearly to support accurate coding.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

A18.83 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.